PRF1 and neoplasm: Compared to pharmacological therapies, CAR-T cells have shown tumor cell killing even in cases with low antigen density, via multiple mechanisms, including direct tumor cell killing by granzymes and perforins and cytokine release, which can recruit other immune cells.49